$HADV ADDITION to below. See site $2.00 PER SHARE Jastlabs
manhattanstreetcapital.com/j…
$TIPS $NXGB $GPFT $VISM $AEFI $AMFN $ECGI $TXTM $BCDS $MASN
$7,500,000 Capital NON DILUTIVE!
$TIPS $NXGB $GPFT $VISM $AEFI $AMFN $ECGI $TXTM $BCDS $MASN
1
171
$HADV 7.5M plus in cash with a market cap of $600,000 plus more in the pipeline!! $MASN $GPFT $TRIPS $EVSV $ECGI
Replying to @OfProfits
2/2 JASTLabs carries a stated $160M val and is allocating 10% of $75m toward $HADV, receiving preferred shares. 5 Pettle linked individuals have positions across the 2 co's, from JAST co-founder & HADV lead scientist to noteholders. HADV's economic interest worth? 10% of $160m.
4
279
$HADV Current par value with 7.5M Cash is .0041 how this isn’t ripping yet it crazy!
Should follow $MASN $TIPS
Great update today! $HADV
10% of that is $7,500,000. Even if authorized shares maxed at 1.9b that puts company at roughly .0039 a share... at current OS it puts company at .0048 a share. Currently? .0001 x .0002 🧐 No brainer imo. I've seen these decide to go out of nowhere many times!
Replying to @MarkBagger
Forgot to mention, $AIDX has an investor/webinar tomorrow at noon: CEO Jonathan Cohen to Discuss Laboratory Franchise Model, 2027 Licensing Plans, Potential Acquisitions, FDA Strategy, and Firefighter Cancer Screening Initiatives
Maybe we get some news flow on it, I like some of the bullets above.
Replying to @greatstockpicks
264
$CYIO being slept on big time. With this SS and majority of the restricted being owned at .02 could make for a monster move from these levels!
$HADV $EMBR $TIPS $AABB $AXXA $NXGB $NICH $UGIZ
1
2
527

























